ZA200706393B - Novel betullnic acid derivatives A-ring-condensed to a heterocyclic group - Google Patents

Novel betullnic acid derivatives A-ring-condensed to a heterocyclic group

Info

Publication number
ZA200706393B
ZA200706393B ZA200706393A ZA200706393A ZA200706393B ZA 200706393 B ZA200706393 B ZA 200706393B ZA 200706393 A ZA200706393 A ZA 200706393A ZA 200706393 A ZA200706393 A ZA 200706393A ZA 200706393 B ZA200706393 B ZA 200706393B
Authority
ZA
South Africa
Prior art keywords
alkyl
acid derivatives
novel
betullnic
condensed
Prior art date
Application number
ZA200706393A
Other languages
English (en)
Inventor
Mukherjee Rama
Mohammad Jamshed Ahmed Siddiqui
Anu T Singh
Singh Manoj Kumar
Jajoo Hemant Kumar
Kumar Vivek
Agarwal Shiv Kumar
Srivastava Sanjay Kumar
Jaggi Manu
Vardhan Anand
Rajendran Praveen
Anand C Burman
Rani Nidhi
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Publication of ZA200706393B publication Critical patent/ZA200706393B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200706393A 2005-02-09 2007-08-01 Novel betullnic acid derivatives A-ring-condensed to a heterocyclic group ZA200706393B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN265DE2005 2005-02-09
PCT/IN2005/000445 WO2006085334A2 (en) 2005-02-09 2005-12-29 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group

Publications (1)

Publication Number Publication Date
ZA200706393B true ZA200706393B (en) 2009-11-25

Family

ID=36793451

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706393A ZA200706393B (en) 2005-02-09 2007-08-01 Novel betullnic acid derivatives A-ring-condensed to a heterocyclic group

Country Status (12)

Country Link
US (1) US8022055B2 (xx)
EP (1) EP1858910B1 (xx)
KR (1) KR101068259B1 (xx)
AT (1) ATE486886T1 (xx)
AU (1) AU2005327442B2 (xx)
BR (1) BRPI0519948A2 (xx)
CA (1) CA2597300C (xx)
DE (1) DE602005024623D1 (xx)
EA (1) EA013158B1 (xx)
NZ (1) NZ560734A (xx)
WO (1) WO2006085334A2 (xx)
ZA (1) ZA200706393B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9062197B2 (en) * 2009-03-27 2015-06-23 Eastman Chemical Company Polyester blends
PL227790B1 (pl) 2015-08-13 2018-01-31 Slaski Univ Medyczny W Katowicach Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie.
JP6820450B2 (ja) 2017-09-14 2021-01-27 フェニックス・バイオテクノロジー・インコーポレイテッド ウイルス感染を治療するための方法および組成物
RU2758376C2 (ru) 2017-09-14 2021-10-28 Феникс Байотекнолоджи, Инк. Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
WO2021201903A1 (en) 2020-03-31 2021-10-07 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection

Also Published As

Publication number Publication date
DE602005024623D1 (de) 2010-12-16
KR20070107717A (ko) 2007-11-07
EP1858910A2 (en) 2007-11-28
AU2005327442A1 (en) 2006-08-17
EA013158B1 (ru) 2010-02-26
WO2006085334A3 (en) 2007-06-14
CA2597300C (en) 2012-11-27
EA200701689A1 (ru) 2008-02-28
US8022055B2 (en) 2011-09-20
AU2005327442B2 (en) 2011-09-01
NZ560734A (en) 2010-09-30
WO2006085334A2 (en) 2006-08-17
ATE486886T1 (de) 2010-11-15
EP1858910B1 (en) 2010-11-03
BRPI0519948A2 (pt) 2009-12-01
KR101068259B1 (ko) 2011-09-28
US20080293682A1 (en) 2008-11-27
CA2597300A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
ES2543607T3 (es) Ciertas amidas sustituidas, método de obtención, y método de su uso
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
MX2011009034A (es) Formas de profarmaco de inhibidores de cinasa y su uso en la terapia.
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
MX2010000658A (es) Derivados de pirimidina 934.
ZA200706393B (en) Novel betullnic acid derivatives A-ring-condensed to a heterocyclic group
IL190971A0 (en) Method and compounds for preparing cc-1065 analogs
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
PH12014500947A1 (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
NZ596615A (en) Substituted isoquinoline derivative
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
CY1107677T1 (el) Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
RS20100169A (xx) Intermedijeri za dobijanje dioksan-2-alkilkarbamata
TW200611687A (en) Pharmaceutical compositions used for immunosuppressant
AR072904A1 (es) Compuestos de fenilamino-isonicotinamida y composiciones farmaceuticas que los contienen
TW200612920A (en) Novel imidazolidine derivatives
TW200609670A (en) Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof
WO2009028387A1 (ja) プロテアーゼ阻害剤耐性を有する癌の治療薬
MY143245A (en) 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
EA200701582A1 (ru) Замещённые 5-фенилпиримидины i в терапии
TW200604161A (en) Chemical process
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof